Company Filing History:

5 out of 1,500

Astrazeneca Ab

Imperial Chemical Industries Limited

patents

Years Active: 1977-2011

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7951830 - Compounds effecting glucokinase (2011-05-31),

2. 7524957 - Compounds effecting glucokinase (2009-04-28),

3. 7390908 - Compounds effecting glucokinase (2008-06-24),

4. 7199140 - Vinyl phenyl derivatives as GLK activators (2007-04-03),

5. 6753331 - Heterocyclic derivatives which inhibit factor Xa (2004-06-22),

6. 6458793 - Heterocyclic derivatives which inhibit factor Xa (2002-10-01),

7. 6258817 - Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof (2001-07-10),

8. 6060475 - Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses (2000-05-09),

9. 5866568 - Heterocyclic compounds (1999-02-02),

10. 5668137 - N-heterocyclic sulfonamides having endothelin receptor activity (1997-09-16),

11. 5380714 - 2-furyl-triazalo [1,5-a]-[1,3,5]triazines and pyrazolo (1995-01-10),

12. 4798846 - Pharmaceutical compositions (1989-01-17),

13. 4452817 - Anaesthetic compositions containing 2,6-diisopropylphenol (1984-06-05),

14. 4056635 - 2,6-Diisopropylphenol as an anaesthetic agent (1977-11-01),

Title: The Innovative Contributions of Roger James

Introduction

Roger James is a notable inventor based in Cheshire, GB, recognized for his significant contributions to the field of medicinal chemistry. With a total of 14 patents to his name, he has made strides in developing compounds that target glucokinase, a key enzyme in glucose metabolism.

Latest Patents

Among his latest patents, Roger has focused on compounds that affect glucokinase. His invention relates to the use of a compound of Formula (I) or a salt, solvate, or prodrug thereof, wherein R, R, R, n, and m are as described in the specification. This compound is intended for the preparation of a medicament for the treatment or prevention of disease conditions mediated through glucokinase (GLK), such as type 2 diabetes. Additionally, the invention introduces a novel group of compounds of Formula (I) and outlines methods for preparing these compounds.

Career Highlights

Roger has had a distinguished career, working with prominent companies in the pharmaceutical industry, including AstraZeneca and Zeneca Limited. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Throughout his career, Roger has collaborated with esteemed colleagues, including Rodney Brian Hargreaves and Peter William Rodney Caulkett. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Roger James exemplifies the spirit of innovation in medicinal chemistry, with his patents paving the way for new treatments for diabetes and other conditions. His work continues to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.